3-ethyldihydrocinnamic acid methyl ester

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 3-ethyldihydrocinnamic acid methyl ester
• 英文别名: methyl 3-ethyldihydrocinnamate；Methyl 3-(3-ethylphenyl)propanoate
• 化学式: C₁₂H₁₆O₂
• 分子量: 192.258
• InChiKey: NKVHOXMXUGYKCT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  14
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-ethyldihydrocinnamic acid methyl ester 在 palladium on activated charcoal 甲醇 、 lithium aluminium tetrahydride 、 正丁基锂 、 (-)-(S)-BINAL-H 、 氢气 、 sodium hexamethyldisilazane 、 二异丁基氢化铝 、 potassium carbonate 、 对甲苯磺酸 、 溶剂黄146 作用下， 以 四氢呋喃 、 乙二醇二甲醚 、 二氯甲烷 、 乙酸乙酯 为溶剂， 生成 7-{(1R,2R,3R,5S)-2-[(R)-5-(3-Ethyl-phenyl)-3-hydroxy-pentyl]-3,5-dihydroxy-cyclopentyl}-heptanoic acid
  参考文献：
  名称：

  Synthesis and in vitro evaluation of human FP-receptor selective prostaglandin analogues

  摘要：

  The in vitro evaluation of a series of saturated prostaglandins revealed that compounds with omega chain aromatic rings retain nanomolar potency for the human prostaglandin F receptor (hFP receptor), exemplified by compound 8. In contrast, the double bonds are required for activity in the series with an acyclic omega chain as in PGF(2 alpha). (C) 2000 Published by Elsevier Science Ltd.

  DOI：

  10.1016/s0960-894x(00)00273-0
• 作为产物：
  描述：

  (E)-3-(3-Ethyl-phenyl)-acrylic acid 在 palladium on activated charcoal 甲醇 、 氢气 作用下， 以 乙酸乙酯 为溶剂， 生成 3-ethyldihydrocinnamic acid methyl ester
  参考文献：
  名称：

  Synthesis and in vitro evaluation of human FP-receptor selective prostaglandin analogues

  摘要：

  The in vitro evaluation of a series of saturated prostaglandins revealed that compounds with omega chain aromatic rings retain nanomolar potency for the human prostaglandin F receptor (hFP receptor), exemplified by compound 8. In contrast, the double bonds are required for activity in the series with an acyclic omega chain as in PGF(2 alpha). (C) 2000 Published by Elsevier Science Ltd.

  DOI：

  10.1016/s0960-894x(00)00273-0

文献信息

• Aldehyde as a Traceless Directing Group for Regioselective C–H Alkylation Catalyzed by Rhodium(III) in Air
  作者：Si-Qi Chen、Xin-Ran Li、Chao-Jun Li、Juan Fan、Zhong-Wen Liu、Xian-Ying Shi

  DOI：10.1021/acs.orglett.9b04433

  日期：2020.2.21

  The aromatic aldehyde as a traceless directing group for the regionselective C-H alkylation catalyzed by rhodium(III) under aerobic atmospheric conditions has been developed. The process involves an aldehyde assisted direct addition of C-H bond to unsaturated electrophiles of acrylates or acrylic acids, and the subsequent decarbonylation. A trace amount of water is found to favor the reaction.

  已经开发出芳香醛作为有氧大气条件下铑（III）催化的区域选择性CH烷基化的无痕导向基团。该方法涉及醛辅助的CH键直接加成到丙烯酸酯或丙烯酸的不饱和亲电子体上，以及随后的脱羰作用。发现痕量的水有利于该反应。
• 一种二氢肉桂酸酯类化合物的合成方法
  申请人：陕西师范大学

  公开号：CN109438238B

  公开（公告）日：2021-04-13

  本发明公开了一种二氢肉桂酸酯类化合物的合成方法，该方法以二氯五甲基环戊二烯基合铑二聚体为催化剂，通过芳香醛的醛基邻位C‑H键与α,β‑不饱和酯类化合物之间发生的共轭加成、脱羰串联反应，简便、高效地一步合成出一系列二氢肉桂酸酯类化合物。本发明具有原料廉价易得、高效、反应操作简单等特点。
• 9-Substituted 8-oxoadenine compound
  申请人：Kurimoto Ayumu

  公开号：US20070190071A1

  公开（公告）日：2007-08-16

  The present invention provides an 8-oxoadenine compound having immunemodulating activities such as an interferon inducing activity and useful as an antiviral agent and antiallergic agent, which is represented by the following formula (1): [wherein the ring A represents a 6-10 membered aromatic carbocyclic ring and the like, R represents a halogen atom, an alkyl group and the like, n represents an integer of 0-2, Z 1 represents alkylene, X 2 represents oxygen atom, sulfur atom, SO 2 , NR 5 , CO, CONR 5 , NR 5 CO and the like, Y 1 , Y 2 and Y 3 represent independently a single bond or an alkylene group, X 1 represents oxygen atom, sulfur atom, NR 4 (R 4 is hydrogen atom or an alkyl group) or a single bond, R 2 represents a substituted or unsubstituted alkyl group, R 1 represents hydrogen atom, hydroxy group, an alkoxy group, an alkoxycarbonyl group or a haloalkyl group] or its pharmaceutically acceptable salt.

  本发明提供了一种具有免疫调节活性的8-氧腺嘌呤化合物，例如干扰素诱导活性，并且可用作抗病毒剂和抗过敏剂，其化学式如下（1）所示：[其中，环A代表6-10个成员的芳香环烷基环等，R代表卤素原子，烷基等，n代表0-2的整数，Z1代表烷基，X2代表氧原子，硫原子，SO2，NR5，CO，CONR5，NR5CO等，Y1，Y2和Y3独立地代表单键或烷基，X1代表氧原子，硫原子，NR4（R4为氢原子或烷基）或单键，R2代表取代或未取代的烷基，R1代表氢原子，羟基，烷氧基，烷氧羰基或卤代烷基]或其药学上可接受的盐。
• SIGMA RECEPTOR BINDERS
  申请人：BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM

  公开号：US20210323913A1

  公开（公告）日：2021-10-21

  Provided herein, inter alia, are compounds and methods of treating diseases including cancer, neurological disease, alcohol withdrawal, depression and anxiety, traumatic brain injury, and neuropathic pain.
• US8012964B2
  申请人：——

  公开号：US8012964B2

  公开（公告）日：2011-09-06